Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc.（SYRE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
syre · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$115
Consensus
$86.64
+20.9% upside
Low
$49.00
Median: $90 · Last Close: $71.69
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$86.64
20.9% upside
High Target
$115
60.4%
Low Target
$49
-31.7%
Current Price
$71.69
as of today
Based on analyst price targets, the SYRE stock price prediction for the next 12 months ranges from $49 to $115. The consensus SYRE price forecast of $86.64 implies 20.9% upside from the current price of $71.69.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $71.76 | ↑ 0.09% |
1-day model range: $71.25–$72.26. Peak: $72.26 (+0.09%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $124 | +73.0% |
| 2028 | $178 | +148.8% |
| 2029 | $225 | +214.2% |
| 2030 | $261 | +263.8% |
| 2031 | — | +298.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SYRE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-04 | Deutsche Bank | Maintains | Buy→Buy |
| 2026-05-06 | Stifel | Maintains | Buy→Buy |
| 2026-05-06 | Citigroup | Maintains | Buy→Buy |
| 2026-04-17 | Jones Trading | Maintains | Buy→Buy |
| 2026-04-14 | Deutsche Bank | Maintains | Buy→Buy |
| 2026-04-14 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-14 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-04-14 | Baird | Maintains | Outperform→Outperform |
| 2026-04-13 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-04-13 | BTIG | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Spyre Therapeutics, Inc. (SYRE) stock. Of the recent 26 rating actions, 2 were upgrades and 0 were downgrades. 11 analysts currently cover SYRE.
分析师推荐趋势
SYRE analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 55.7% YoY
Revenue Next Year
$0M
↑ 88.1% YoY
EPS This Year
$-2.93
EPS Next Year
$-3.19
↑ 8.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast SYRE EPS of $-2.93 for the current fiscal year, based on estimates from 10 analysts. The SYRE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SYRE 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SYRE 的共识目标价为 $86.64（+20.9% 上行空间），分析师共识为 Buy。
SYRE 的短期预测（明日）为 $71.76（+0.09%）。 SYRE 对 2027 年的股价预测均值为 $124。 SYRE 对 2030 年的预测区间为 $241–$281。
Spyre Therapeutics, Inc. 在 NASDAQ 上市，代码 SYRE。SYRE 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
SYRE 预测 · 8 个问题根据 11 位华尔街分析师，SYRE 的 12 个月平均目标价为 $86.64，最高 $115.00、最低 $49.00。若有图表，中位目标价可在上方查看。相对当前价 $71.69，隐含约 +20.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.